ENTITY
Astrazeneca Plc Spons Adr

Astrazeneca Plc Spons Adr (AZN US)

100
Analysis
Health CareUnited Kingdom
AstraZeneca PLC is a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia, and Infection.
more
bullishPfizer
12 Apr 2021 00:00Exchange-sponsored

SGX Asia Currencies and Commodities Insights

By Macro Hive   SGX Asia Currencies Insights CNH has traded well against most currencies, and flows remain strong. Therefore, recent USD/CNH...

Share
bullishSK Bioscience
08 Mar 2021 22:50

Trading Strategy of SK Bioscience IPO Post Pricing

The IPO price of SK Bioscience was confirmed at 65,000 won per share, which is at the top of the IPO price range. The total demand ratio of the SK...

Logo
302 Views
Share
bullishAstraZeneca PLC
23 Feb 2021 22:39Issuer-paid

Video: Oxford Biomedica – executive interview

Why are investors buying into Oxford Biomedica (LN:OXB)? In this interview, BBC broadcaster Vivienne Parry OBE asks CEO John Dawson why Oxford...

Share
bullishI-Mab
08 Feb 2021 14:33

I-Mab Placement - Heading in the Right Direction

A group of shareholders plans to raise around US$200m via selling a 4.6% stake in I-Mab (IMAB US). We have previously covered the IPO as well.

Logo
233 Views
Share
28 Jan 2021 11:43

Cathay Pacific (293 HK): Back To Terminal

Vaccine rollout and a hard turnaround in global tourism/air travel appear highly optimistic. I think Cathay has further to fall from here.

Logo
374 Views
Share
x